These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 9864481)
1. [Treatment results and the prognosis in patients with localization of non-Hodgkins-lymphoma in the central nervous system]. Paulus JA; Bos GM; Löwenberg B; Van Den Bent MJ Ned Tijdschr Geneeskd; 1998 Oct; 142(40):2196-200. PubMed ID: 9864481 [TBL] [Abstract][Full Text] [Related]
2. Primary non-Hodgkin's lymphoma of the CNS treated with CHOD/BVAM or BVAM chemotherapy before radiotherapy: long-term survival and prognostic factors. Bessell EM; Graus F; Lopez-Guillermo A; Lewis SA; Villa S; Verger E; Petit J Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):501-8. PubMed ID: 15145169 [TBL] [Abstract][Full Text] [Related]
3. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage]. Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383 [TBL] [Abstract][Full Text] [Related]
5. Diagnosis and treatment of central nervous system involvement in non-Hodgkin's lymphoma. Bierman P; Giglio P Hematol Oncol Clin North Am; 2005 Aug; 19(4):597-609, v. PubMed ID: 16083825 [TBL] [Abstract][Full Text] [Related]
6. Prophylactic intrathecal methotrexate and hydrocortisone reduces central nervous system recurrence and improves survival in aggressive non-hodgkin lymphoma. Tomita N; Kodama F; Kanamori H; Motomura S; Ishigatsubo Y Cancer; 2002 Aug; 95(3):576-80. PubMed ID: 12209750 [TBL] [Abstract][Full Text] [Related]
7. Ocular presentation of primary central nervous system lymphoma: diagnosis and treatment. Hormigo A; Abrey L; Heinemann MH; DeAngelis LM Br J Haematol; 2004 Jul; 126(2):202-8. PubMed ID: 15238140 [TBL] [Abstract][Full Text] [Related]
8. [Intraocular lymphoma--a clinical study of 14 patients with non-Hodgkin's lymphoma]. Ríhová E; Sisková A; Jandusová J; Kovarík Z; Sach J; Adam P Cesk Slov Oftalmol; 2004 Jan; 60(1):3-16. PubMed ID: 15011301 [TBL] [Abstract][Full Text] [Related]
9. [Primary central nervous system lymphoma: a report of 28 patients]. Hu Y; Feng FY; Shi YK; Zhou LQ; Gu DZ; Wang QL Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):375-8. PubMed ID: 15312352 [TBL] [Abstract][Full Text] [Related]
10. [Clinical features, treatment and prognosis of 136 patients with primary non-Hodgkin's lymphoma of the nasopharynx]. Yuan ZY; Li YX; Zhao LJ; Gao YH; Liu XF; Gu DZ; Qian TN; Yu ZH Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):425-9. PubMed ID: 15355649 [TBL] [Abstract][Full Text] [Related]
11. Treatment results of tonsillar lymphoma: a 10-year experience. Mohammadianpanah M; Omidvai S; Mosalei A; Ahmadloo N Ann Hematol; 2005 Apr; 84(4):223-6. PubMed ID: 15042316 [TBL] [Abstract][Full Text] [Related]
12. The role of craniospinal irradiation in adults with a central nervous system recurrence of leukemia. Sanders KE; Ha CS; Cortes-Franco JE; Koller CA; Kantarjian HM; Cox JD Cancer; 2004 May; 100(10):2176-80. PubMed ID: 15139061 [TBL] [Abstract][Full Text] [Related]
13. Clinical features and predictors of survival of AIDS-related non-Hodgkin's lymphoma in a population-based case series in Sydney, Australia. Robotin MC; Law MG; Milliken S; Goldstein D; Garsia RJ; Dolan GM; Kaldor JM; Grulich AE HIV Med; 2004 Sep; 5(5):377-84. PubMed ID: 15369514 [TBL] [Abstract][Full Text] [Related]
14. Primary central nervous system lymphoma. Results at the University of California at Los Angeles and review of the literature. Selch MT; Shimizu KT; De Salles AF; Sutton C; Parker RG Am J Clin Oncol; 1994 Aug; 17(4):286-93. PubMed ID: 8048389 [TBL] [Abstract][Full Text] [Related]
15. Primary non-Hodgkin lymphoma of the breast: The Mayo Clinic Experience. Wong WW; Schild SE; Halyard MY; Schomberg PJ J Surg Oncol; 2002 May; 80(1):19-25; discussion 26. PubMed ID: 11967901 [TBL] [Abstract][Full Text] [Related]
16. [Treatment option and outcome for patients with primary non-Hodgkin's lymphoma of the nasal cavity]. Yao B; Li YX; Song YW; Jin J; Liu YP; Wang WH; Wang SL; Sun YT; Yu ZH; Liu XF Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):58-61. PubMed ID: 16737624 [TBL] [Abstract][Full Text] [Related]
17. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue. Hagemeister FB Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984 [TBL] [Abstract][Full Text] [Related]
18. Retrospective study of prognostic factors in non-Hodgkin lymphoma secondarily involving the central nervous system. Jahnke K; Thiel E; Martus P; Schwartz S; Korfel A Ann Hematol; 2006 Jan; 85(1):45-50. PubMed ID: 16132909 [TBL] [Abstract][Full Text] [Related]
19. Multi-modality therapy leads to longer survival in primary central nervous system lymphoma patients. Singhal D; Witham TF; Germanwala A; Flickinger JC; Schiff D; Kondziolka D Can J Neurol Sci; 2002 May; 29(2):147-53. PubMed ID: 12035835 [TBL] [Abstract][Full Text] [Related]
20. High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962. Poortmans PM; Kluin-Nelemans HC; Haaxma-Reiche H; Van't Veer M; Hansen M; Soubeyran P; Taphoorn M; Thomas J; Van den Bent M; Fickers M; Van Imhoff G; Rozewicz C; Teodorovic I; van Glabbeke M; J Clin Oncol; 2003 Dec; 21(24):4483-8. PubMed ID: 14597741 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]